Viewing Study NCT06947460


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-06-04 @ 4:02 AM
Study NCT ID: NCT06947460
Status: RECRUITING
Last Update Posted: 2025-05-13
First Post: 2025-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
Sponsor: Beijing GoBroad Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Lupus Nephritis View
None Systemic Sclerosis View
None Primary Sjogren's Syndrome Combined With Pulmonary Hypertension View
Keywords: